Perspectives

CPS Specialty Pharmacy Research Named Top 5% at ISPOR 2026

Written by CPS | May 18, 2026 6:55:44 PM

Published: May 2026

Congratulations to our CPS authors!

 

It’s an honor to share that CPS’ specialty pharmacy research has been featured this week at ISPOR 2026 and recognized as a Top 5% Finalist for the ISPOR 2026 Research Presentation Awards.

 

The study, "Identifying Determinants of Medication Persistence in Rheumatoid Arthritis Using Machine Learning and Regression Analysis," outlines how health-system specialty pharmacies (HSSPs) can influence medication persistence among patients with rheumatoid arthritis by supporting medication access, clinical management, and monitoring.

 

Learn more about the esteemed research presented at ISPOR here.